Repeated-dose Behavioral Intervention to Reduce Opioid Overdose
NCT03838510 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 268
Last updated 2025-06-15
Summary
REBOOT is a randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among naloxone recipients with opioid use disorder. It includes an established overdose education curriculum within an Informational-Motivation-Behavior (IMB) model. This study will test the efficacy of REBOOT vs attention-control.
Conditions
- Opioid-Related Disorders
- Drug Overdose
Interventions
- BEHAVIORAL
-
REBOOT
The brief counseling intervention will utilize Motivational Interviewing and skills-building techniques to modify personal overdose risk behaviors and develop skills as a peer responder for witnessed overdose. The counselor will draw upon themes of safer substance use to address overdose risk behaviors and determine readiness for change in substance use.
Sponsors & Collaborators
-
San Francisco Department of Public Health
lead OTHER_GOV
Principal Investigators
-
Phillip O Coffin, MD, MIA · San Francisco Department of Public Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-22
- Primary Completion
- 2023-12-12
- Completion
- 2023-12-12
Countries
- United States
Study Locations
More Related Trials
-
Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments
NCT03821103 ·Status: COMPLETED ·Phase: NA
-
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
NCT00577408 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults
NCT01046539 ·Status: COMPLETED ·Phase: PHASE1
-
Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers
NCT02871232 ·Status: UNKNOWN
-
Improved Strategies for Outpatient Opioid Detoxification
NCT01377610 ·Status: COMPLETED ·Phase: PHASE1
-
Increasing Patient Knowledge of the Signs of Opioid Overdose and Naloxone in a Suburban Treatment Program
NCT02120612 ·Status: COMPLETED
-
Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site
NCT00781898 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
NCT00000331 ·Status: WITHDRAWN ·Phase: PHASE2
-
Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment
NCT06367387 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
User Acceptability of a Device-Based Opioid Overdose Intervention
NCT04530591 ·Status: COMPLETED
-
XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept
NCT03604159 ·Status: COMPLETED ·Phase: PHASE4
-
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
NCT00000299 ·Status: COMPLETED ·Phase: PHASE2
-
Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose
NCT06316830 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
NCT00000344 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Mindfulness on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment (R33 Phase)
NCT04278586 ·Status: COMPLETED ·Phase: NA
-
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
NCT04464980 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care
NCT01893827 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
NCT05118204 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
NCT05011266 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
NCT00000330 ·Status: WITHDRAWN ·Phase: PHASE2
-
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
NCT02357901 ·Status: COMPLETED ·Phase: PHASE3
-
Mindfulness-Based Relapse Prevention to Improve Medication Assisted Treatment Adherence and Drug-use Outcomes for Opioid Use Disorder
NCT05042388 ·Status: COMPLETED ·Phase: NA
-
Abuse Liability of Suboxone Versus Subutex
NCT00710385 ·Status: COMPLETED ·Phase: PHASE3
-
Neurobehavioral Mechanisms of Choice in Opioid Use Disorder
NCT03958474 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy
NCT03337100 ·Status: COMPLETED ·Phase: NA